泰拉维万是一种用于MRSA或其他革兰氏阳性感染的杀菌脂肽,是万古霉素的半合成衍生物。2009年9月,FDA批准了用于复杂皮肤和皮肤结构感染(cSSSI)的药物,2013年6月批准用于由金黄色葡萄球菌引起的医院获得性和呼吸机相关性细菌性肺炎。

清空选项
1404-90-6 (3S,6R,7R,22R,23S,26S,36R,38aR)-3-(2-Amino-2-oxoethyl)-44-[[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-α-L-lyxo-hexopyranosyl)-β-D-glucopyranosyl]oxy]-10,19-dichloro-2,3,4,5,6,7,23,24,25,26,36,37,38,38a-tetradecahydro-7,22,28,30,32-pentahydroxy-6-[[(2R)-4-methyl-2-(methylamino)-1-oxopentyl]amino]-2,5,24,38,39-pentaoxo-22H-8,11:18,21-Dietheno-23,36-(iminomethano)-13,16:31,35-dimetheno-1H,16H-[1,6,9]oxadiazacyclohexadecino[4,5-m][10,2,16]benzoxadiazacyclotetracosine-26-carboxylic acid
BD1563411404-90-6≥950μg/mg
¥46.00250mg常备现货
1066-51-9 (Aminomethyl)phosphonic acid
BD464331066-51-997%
¥33.00250mg常备现货
239088-22-3 (9H-Fluoren-9-yl)methyl decyl(2-oxoethyl)carbamate
BD46410239088-22-398+%
¥1001.005g
1